High expression of TRIP13 is associated with tumor progression in H. pylori infection induced gastric cancer
- PMID: 38492425
- DOI: 10.1016/j.mrfmmm.2024.111854
High expression of TRIP13 is associated with tumor progression in H. pylori infection induced gastric cancer
Abstract
Background/objective: H. pylori is a recognized bacterial carcinogen in the world to cause gastric cancer (GC). However, the molecular mechanism of H. pylori infection-induced GC is not completely clear. Thus, there is an urgent need to reveal the precise mechanisms regulating cancer development due to H. pylori infection.
Methods: GEO microarray databases and TCGA databases were extracted for the analysis of different expression genes (DEGs). Then, Kaplan-Meier Plotter was used for prognostic analysis. Functional enrichment analysis of TRIP13 was performed by metascape database and TIMER database. Specific role of TRIP13 in GC with H. pylori infection was confirmed by CCK8, cell cycle analysis and WB.
Results: A total 10 DEGs were substantially elevated in GC and H. pylori+ tissues and might be associated with H. pylori infection in GC and only the highly expressed TRIP13 was statistically associated with poor prognosis in GC patients. Meanwhile, TRIP13 were upregulated in both CagA-transfected epithelial cells and GC cells. And TRIP13 deficiency inhibited cell proliferation and arrested the cell cycle at the G1 phase.
Conclusion: Our study suggested that high expression of TRIP13 can promote the proliferation, cell cycle in GC cells, which could be used as a biomarker for H. pylori infection GC.
Keywords: Bioinformatics analysis; Cell cycle; Gastric cancer; H. pylori infection; TRIP13.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors state that there are no conflicts of interest to disclose.
Similar articles
-
Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a "hit-and-run" paradigm.Cancer Commun (Lond). 2025 May;45(5):608-631. doi: 10.1002/cac2.70004. Epub 2025 Feb 17. Cancer Commun (Lond). 2025. PMID: 39960839 Free PMC article.
-
Enhanced LRP8 expression induced by Helicobacter pylori drives gastric cancer progression by facilitating β-Catenin nuclear translocation.J Adv Res. 2025 Mar;69:299-312. doi: 10.1016/j.jare.2024.04.002. Epub 2024 Apr 10. J Adv Res. 2025. PMID: 38609049 Free PMC article.
-
Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-κB-mediated expression of CEACAM1-3S in human gastric cancer.Gastric Cancer. 2019 Sep;22(5):941-954. doi: 10.1007/s10120-019-00932-0. Epub 2019 Feb 18. Gastric Cancer. 2019. PMID: 30778796 Free PMC article.
-
Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer.Gastroenterol Clin North Am. 2015 Sep;44(3):625-38. doi: 10.1016/j.gtc.2015.05.011. Epub 2015 Jul 7. Gastroenterol Clin North Am. 2015. PMID: 26314672 Review.
-
MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application.Pharmacol Res. 2024 Jul;205:107216. doi: 10.1016/j.phrs.2024.107216. Epub 2024 May 16. Pharmacol Res. 2024. PMID: 38761883 Review.
Cited by
-
Discovery of novel antimyeloma agents targeting TRIP13 by molecular modeling and bioassay.RSC Med Chem. 2025 May 6. doi: 10.1039/d4md01008f. Online ahead of print. RSC Med Chem. 2025. PMID: 40337305 Free PMC article.
-
TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21.Cell Death Dis. 2024 Aug 26;15(8):622. doi: 10.1038/s41419-024-07012-x. Cell Death Dis. 2024. PMID: 39187490 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous